Last updated on February 2018

A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis


Brief description of study

This is a multicenter, randomized, double-blind phase2 study to evaluate the safety and investigate the efficacy of YRA-1909 in Patients with Rheumatoid Arthritis who are on a stable dose of Methotrexate(MTX) and who have an inadequate response to MTX(MTX-IR).

Clinical Study Identifier: NCT03275025

Contact Investigators or Research Sites near you

Start Over

Hyun Ah Kim, MD

Hanllym University Medical Center
Anyang, Korea, Republic of
  Connect »

Changhui Seo, MD

Ajou University Hospital
Suwon, Korea, Republic of
9.85miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.